These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12482496)

  • 1. Clinical implications of antigen transfer mechanisms from malignant to dendritic cells. exploiting cross-priming.
    Arina A; Tirapu I; Alfaro C; Rodríguez-Calvillo M; Mazzolini G; Inogés S; López A; Feijoo E; Bendandi M; Melero I
    Exp Hematol; 2002 Dec; 30(12):1355-64. PubMed ID: 12482496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting dendritic cells for priming cellular immune responses.
    Gogolák P; Réthi B; Hajas G; Rajnavölgyi E
    J Mol Recognit; 2003; 16(5):299-317. PubMed ID: 14523943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy.
    Sánchez-Paulete AR; Teijeira A; Cueto FJ; Garasa S; Pérez-Gracia JL; Sánchez-Arráez A; Sancho D; Melero I
    Ann Oncol; 2017 Dec; 28(suppl_12):xii44-xii55. PubMed ID: 28945841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained cross-presentation capacity of murine splenic dendritic cell subsets in vivo.
    Ho NI; Camps MGM; de Haas EFE; Ossendorp F
    Eur J Immunol; 2018 Jul; 48(7):1164-1173. PubMed ID: 29676785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini-review: Regulation of cytotoxic T lymphocyte responses by dendritic cells: peaceful coexistence of cross-priming and direct priming?
    Melief CJ
    Eur J Immunol; 2003 Oct; 33(10):2645-54. PubMed ID: 14515248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
    Steinman RM
    Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of dendritic cells in recognizing antigens: their binding, transformation and presentation to T lymphocytes].
    Kołodziej D; Pajtasz-Piasecka E
    Postepy Hig Med Dosw; 2003; 57(2):149-70. PubMed ID: 12866353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen presentation and T cell stimulation by dendritic cells.
    Guermonprez P; Valladeau J; Zitvogel L; Théry C; Amigorena S
    Annu Rev Immunol; 2002; 20():621-67. PubMed ID: 11861614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling.
    Bendz H; Ruhland SC; Pandya MJ; Hainzl O; Riegelsberger S; Braüchle C; Mayer MP; Buchner J; Issels RD; Noessner E
    J Biol Chem; 2007 Oct; 282(43):31688-702. PubMed ID: 17684010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
    Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity.
    Noubade R; Majri-Morrison S; Tarbell KV
    Front Immunol; 2019; 10():1014. PubMed ID: 31143179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells.
    Pinho MP; Sundarasetty BS; Bergami-Santos PC; Steponavicius-Cruz K; Ferreira AK; Stripecke R; Barbuto JA
    Cytotherapy; 2016 Apr; 18(4):570-80. PubMed ID: 26971685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of bacterial antigens for peptide presentation on MHC class I molecules.
    Wick MJ; Ljunggren HG
    Immunol Rev; 1999 Dec; 172():153-62. PubMed ID: 10631944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.
    Brusa D; Garetto S; Chiorino G; Scatolini M; Migliore E; Camussi G; Matera L
    Vaccine; 2008 Nov; 26(50):6422-32. PubMed ID: 18848858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
    Mitchell DA; Nair SK; Gilboa E
    Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.